Submit your abstract

Submit your abstract

Abstract submission

Congress delegates are cordially invited to submit abstracts of their scientific work for presentation as a free communication at the IFCC-EFLM EuroMedLab Brussels 2025      Congress. An unlimited number of abstracts may be submitted provided the presenting author applies for “full registration” or “young registration”. Abstracts are welcome in all fields of clinical chemistry, haematology, clinical molecular biology and laboratory medicine, in the broader sense.

Abstracts will primarily be presented via poster.

A limited number of abstracts will be selected also for oral presentation during congress symposia. Authors wishing to compete for these oral communication slots should mark the appropriate field on the on-line abstract-submission form.

How to submit your abstract

General requirements

The text must be clear, concise, and written in proper English. The content must not have been previously published in academic journals or subject to peer review. Significant technical information must not be withheld. Abstracts must absolutely contain results. Statements such as “results will be discussed” are not acceptable and will lead to rejection.

Deadline for abstract submission

 15th January 2025, 18:30 CET 

General information

Deadline for receipt

Abstracts should be submitted by 15th January 2025, 18:30 CET.

Confirmation of receipt

Receipt of the abstract will be acknowledged by e-mail immediately after submission.

Notification of acceptance or rejection

Authors will be notified of acceptance or rejection within 28th February 2025.

Registration

The presenting author of each abstract must register for the congress with “Full Registration” or “Young Registration”.
IMPORTANT: when submitting the abstract, please make sure to indicate as presenting author the person who will register and attend the Congress (no other authors). The presenting author cannot be modified after the submission.

Abstract topics

  • Accreditation, Patient Safety, Risk management, Quality Assurance, Audit
  • Artificial intelligence, clinical decision support and machine learning
  • Cardiovascular disease; risk assessment; lipids; lipoproteins; cardiac markers
    Clinical Chemistry
  • Data Science , Digital health, big data and smart technologies
  • Demand/test utilization management
  • Direct to consumer testing
  • Disease specific biomarkers: autoimmune, bone, cardiac, cancer, diabetes, neurological, sepsis, traumatic brain injury, …
  • Emerging & Analytical technologies, applications and limitations
  • Emerging biomarkers (-omics type, …)
  • Endocrinology
  • Evidence based medicine, including Guidelines
  • Genetic diseases
  • Geriatric testing
  • Green laboratories
  • Healthcare reform: from curative to preventive
  • Hematology and hemostasis
  • Immunology
  • Kidney diseases and transplantation, urinalysis, urinary biomarkers
  • Laboratory consolidation, Total lab automation and process design
  • Laboratory Information Systems and globalization of NPU
  • Laboratory Management, Medical leadership
  • Metabolic diseases
  • Metrological traceability and test standardization/harmonization
  • Microbiology – Infectious diseases including COVID 19
  • Molecular diagnostics, including CTC and ctDNA
  • Neonatal and paediatric laboratory medicine, including prenatal testing
  • Nutrition Trace Elements and Vitamins
  • Point of Care testing, critical care, emergency medicine
  • Precision Diagnostics and Precision Medicine
  • Recruitment, Education and Training of workforces in Laboratory Medicine
  • Reference Intervals: Direct/Indirect; population vs personal reference intervals
  • Regulations and Regulatory Science, including suboptimal tests and post-market follow-up
  • Remote monitoring and preanalytical challenges
  • Test Evaluation, outcome studies, clinical utility of biomarkers
  • Total Test process, including preanalytics, analytics and postanalytics
  • Toxicology and TDM
  • Others

How to prepare and submit an abstract

It is important to carefully follow the instructions below. Incorrectly prepared abstracts will be rejected.

1. Abstracts should be prepared off-line in advance;
2. Prepare your abstract on a word processor (such as Microsoft Word);
3. Do not include title, authors’ names and affiliations in the abstract file
4. Tables and figures are not allowed
5. References are not allowed
6.When abbreviations are used, spell out the full word at first mention in the text followed by the abbreviation in parentheses. Thereafter, use the abbreviation throughout.
7. When the on-line system requires the abstract to be entered, copy and paste your text. In case your text includes special characters (apex, subscript, Greek letters, etc.), please note that they should be inserted through the appropriate buttons which you can find in the online submission system.
8. Abstracts are limited to 2300 characters, spaces included (title, authors’ names and affiliations excluded). The system will automatically notify you if the abstract exceeds this number of characters.
9. Title, author(s) and affiliation(s) must be added separately at the appropriate step.

IMPORTANT NOTICE

Abstract authors are asked to indicate the most suitable topic for presentation of their work and will

also be asked whether they wish apply for an oral presentation during the scientific symposia.